Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Neurosteroids are crucial for stress response, and targeting specific receptors may help treat certain disorders.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Certain drugs can block changes in brain receptors caused by alcohol withdrawal.

2Br-Crebanine and Stephanine reduce inflammation and pain effectively.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Baricitinib was effective in treating both early and late onset alopecia areata.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Five preservatives may disrupt hormone function and need more health and environmental risk assessment.

Baricitinib successfully treated myasthenia gravis and alopecia in a patient.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

AMPK activation may reduce melanoma risk in red-haired individuals.